These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3245695)

  • 1. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.
    Flaherty JF; Rodondi LC; Guglielmo BJ; Fleishaker JC; Townsend RJ; Gambertoglio JG
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1825-9. PubMed ID: 3245695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis.
    Klepser ME; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1997 Mar; 41(3):630-5. PubMed ID: 9056005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate.
    Plaisance KI; Drusano GL; Forrest A; Townsend RJ; Standiford HC
    Antimicrob Agents Chemother; 1989 May; 33(5):618-20. PubMed ID: 2751277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
    Ruangweerayut R; Looareesuwan S; Hutchinson D; Chauemung A; Banmairuroi V; Na-Bangchang K
    Malar J; 2008 Oct; 7():225. PubMed ID: 18973702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pharmacokinetics of clindamycin hydrochloride in normal dogs when administered at two dosage regimens.
    Saridomichelakis MN; Athanasiou LV; Salame M; Chatzis MK; Katsoudas V; Pappas IS
    Vet Dermatol; 2011 Oct; 22(5):429-35. PubMed ID: 21418348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.
    Sprandel KA; Schriever CA; Pendland SL; Quinn JP; Gotfried MH; Hackett S; Graham MB; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4597-605. PubMed ID: 15561831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.
    Lewis RE; Klepser ME; Ernst EJ; Lund BC; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2005-9. PubMed ID: 10428927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.
    Occhipinti DJ; Pendland SL; Schoonover LL; Rypins EB; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2511-7. PubMed ID: 9371358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.
    Wenzler E; Bleasdale SC; Sikka M; Bunnell KL; Finnemeyer M; Rosenkranz SL; Danziger LH; Rodvold KA;
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clindamycin in pregnant women in the peripartum period.
    Muller AE; Mouton JW; Oostvogel PM; Dörr PJ; Voskuyl RA; DeJongh J; Steegers EA; Danhof M
    Antimicrob Agents Chemother; 2010 May; 54(5):2175-81. PubMed ID: 20176904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.
    Gatti G; Flaherty J; Bubp J; White J; Borin M; Gambertoglio J
    Antimicrob Agents Chemother; 1993 May; 37(5):1137-43. PubMed ID: 8517703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Pharmacodynamics of Levornidazole in Patients With Intra-abdominal AnaerobicInfection.
    Wu H; Xie S; Yu J; Chen Y; Wu J; Guo B; Zhu Z; Zhou Y; Wang Z; Zhang J
    Clin Ther; 2018 Sep; 40(9):1548-1555. PubMed ID: 30146271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
    Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
    J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of clindamycin hydrochloride in homogenates of normal dog skin when administered at two oral dosage regimens.
    Saridomichelakis MN; Athanasiou LV; Chatzis MK; Salame M; Katsoudas V; Pappas IS
    Vet Q; 2013; 33(1):7-12. PubMed ID: 23445168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics study of two different clindamycin capsule formulations: a randomized, two-period, two-sequence, two-way crossover clinical trial in healthy volunteers.
    Sanki UK; Mandal BK; Chandrakala V
    Arzneimittelforschung; 2011; 61(9):538-43. PubMed ID: 22029232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
    Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
    Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):247-53. PubMed ID: 3956142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.